Pevifoscorvir Sodium
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pevifoscorvir Sodium, covering 2026-02-04 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function [Phase 1]